Cargando…

Practice patterns and outcomes of equivocal bone scans for patients with castration-resistant prostate cancer: Results from SEARCH

OBJECTIVE: To review follow-up imaging after equivocal bone scans in men with castration resistant prostate cancer (CRPC) and examine the characteristics of equivocal bone scans that are associated with positive follow-up imaging. METHODS: We identified 639 men from five Veterans Affairs Hospitals w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanyok, Brian T., Everist, Mary M., Howard, Lauren E., De Hoedt, Amanda M., Aronson, William J., Cooperberg, Matthew R., Kane, Christopher J., Amling, Christopher L., Terris, Martha K., Freedland, Stephen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Second Military Medical University 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595156/ https://www.ncbi.nlm.nih.gov/pubmed/31297315 http://dx.doi.org/10.1016/j.ajur.2019.01.004

Ejemplares similares

Predicting bone scan positivity in non-metastatic castration-resistant prostate cancer
por: Moreira, Daniel M., et al.
Publicado: (2015)

Validity of the National Death Index to Ascertain the Date and Cause of Death in Men Having Undergone Prostatectomy for Prostate Cancer
por: Moghanaki, Drew, et al.
Publicado: (2019)

A modeling study to estimate prostate cancer‐specific mortality on active surveillance for men with favorable intermediate‐risk prostate cancer: Results from the SEARCH cohort
por: Kuhlmann, Paige K., et al.
Publicado: (2023)

Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs Cohort
por: Vaculik, Kristina, et al.
Publicado: (2021)

Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy
por: Kelkar, Sonia, et al.
Publicado: (2021)

Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database
por: Vidal, A C, et al.
Publicado: (2017)

Red Blood Cell Distribution Width Is Associated with All-cause Mortality but Not Adverse Cancer-specific Outcomes in Men with Clinically Localized Prostate Cancer Treated with Radical Prostatectomy: Findings Based on a Multicenter Shared Equal Access Regional Cancer Hospital Registry
por: Orabi, Hazem, et al.
Publicado: (2022)

Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database
por: Allott, Emma H., et al.
Publicado: (2013)

The Influence of Hepatic Function on Prostate Cancer Outcomes Following Radical Prostatectomy
por: Bañez, Lionel L., et al.
Publicado: (2010)

Bone scan positivity in non-metastatic, castrate-resistant prostate cancer: external validation study
por: Johnston, Ashley W., et al.
Publicado: (2020)

MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
por: Nickols, Nicholas G., et al.
Publicado: (2019)

Exposure to Agent Orange and Risk of Bladder Cancer Among US Veterans
por: Williams, Stephen B., et al.
Publicado: (2023)

UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression
por: Grant, Delores J., et al.
Publicado: (2017)

Insulinoma with equivocal imaging
por: Belabed, Wafa, et al.
Publicado: (2023)

Equivocal test results and prognostic staging uncertainties in the evaluation of patients with cancer of the prostate.
por: Clemens, J. D., et al.
Publicado: (1986)

Are higher follicle-stimulating hormone levels before androgen deprivation therapy for prostate cancer associated with oncological and cardiac outcomes and overall survival?—a population-level analysis
por: Dymanus, Kyle, et al.
Publicado: (2023)

White Blood Cell Scintigraphy for Fracture-Related Infection: Is Semiquantitative Analysis of Equivocal Scans Accurate?
por: Bosch, Paul, et al.
Publicado: (2021)

Nutrition, dietary interventions and prostate cancer: the latest evidence
por: Lin, Pao-Hwa, et al.
Publicado: (2015)

Observations in Support of Equivocal Generation
Publicado: (1811)

Ocular Equivocation: The Rivalry Between Wheatstone and Brewster
por: Wade, Nicholas J.
Publicado: (2019)

Healthcare Costs in Men with Metastatic Castration-Resistant Prostate Cancer: An Analysis of US Medicare Fee-For-Service Claims
por: Freedland, Stephen J., et al.
Publicado: (2023)

Accommodating heterogeneous missing data patterns for prostate cancer risk prediction
por: Neumair, Matthias, et al.
Publicado: (2022)

Estimated Costs and Long-term Outcomes of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guérin in the Veterans Affairs Health System
por: Williams, Stephen B., et al.
Publicado: (2021)

Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer
por: George, Daniel J., et al.
Publicado: (2021)

Treatment patterns and survival in metastatic castration‐sensitive prostate cancer in the US Veterans Health Administration
por: Freedland, Stephen J., et al.
Publicado: (2021)

Dietary inflammatory index (DII) and risk of prostate cancer in a case-control study among Black and White US Veteran men
por: Vidal, Adriana C., et al.
Publicado: (2019)

Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer
por: Fallara, Giuseppe, et al.
Publicado: (2023)

The equivocal appendix at CT: prevalence in a control population
por: Webb, Emily M., et al.
Publicado: (2009)

Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer
por: Anand, Aseem, et al.
Publicado: (2022)

An Equivocal SCC Lesion—Antiepileptic-Induced CLOCC
por: Kuczyńska, Maryla, et al.
Publicado: (2022)

Weight loss via a low-carbohydrate diet improved the intestinal permeability marker, zonulin, in prostate cancer patients
por: Lin, Pao-Hwa, et al.
Publicado: (2022)

The prevalence and prognosis of next‐generation therapeutic targets in metastatic castration‐resistant prostate cancer
por: Pan, Jian, et al.
Publicado: (2022)

Management of Patients with Metastatic Castration-Sensitive Prostate Cancer in the Real-World Setting in the United States
por: Ryan, Charles J., et al.
Publicado: (2021)

Reappraisal of glucocorticoids in castrate-resistant prostate cancer
por: Sartor, Oliver, et al.
Publicado: (2014)

Current perspectives on bone metastases in castrate-resistant prostate cancer
por: Logothetis, Christopher, et al.
Publicado: (2018)

MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?
por: Schoots, Ivo G.
Publicado: (2018)

Assessing and Enhancing the Welfare of Animals with Equivocal and Reliable Cues
por: Watters, Jason V., et al.
Publicado: (2019)

Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
por: Agersborg, Sally, et al.
Publicado: (2018)

Effect of Dietary Omega-3 Fatty Acids on Castrate Resistant Prostate Cancer and Tumor Associated Macrophages
por: Liang, Pei, et al.
Publicado: (2019)

Real-world evidence of patients with metastatic castration-resistant prostate cancer treated with cabazitaxel: comparison with the randomized clinical study CARD
por: de Wit, Ronald, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1i5gpsbf94s9k14gcr7beilvd7